PGAM5 was identified as novel activation of WβC signaling at cytosolic levels, thereby activating mitochondrial biogenesis [264]; whereas the mitochondrial form of PGAM5 suppresses WβC signaling and leads to mitophagy in SMA [265]. This evidence concerns the gene PGAM5 and proximal spinal muscular atrophy.